Technical Articles

PD1/PD-L1
免疫检查点抑制剂疗效预测的生物标志物
Biomarkers for predicting the efficacy of immune checkpoint inhibitors
发布时间 2026-02-12
Immune checkpoint blockade therapy, represented by PD-1/PD-L1 inhibitors, is a major breakthrough in the field of cancer treatment.
View details
  • Cancer
  • PD1/PD-L1
  • Immune checkpoint inhibitor
  • Cancer therapy
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.